Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors
暂无分享,去创建一个
Peter J. Smith | D. Ashley | Deborah L. Scarcella | E. Algar | Sally L Dennis | Shehnaaz S M Manji | Darryl P Carrington | Deborah L Scarcella | David M Ashley | Peter J Smith | Elizabeth M Algar | S. S. Manji | Sally L. Dennis | Darryl P. Carrington | Shehnaaz S. M. Manji
[1] U. Gullberg,et al. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program , 1998, Oncogene.
[2] Peter J. Smith,et al. CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance , 1999, Journal of medical genetics.
[3] C. Y. Wang,et al. WT1 modulates apoptosis by transcriptionally upregulating the bcl‐2 proto‐oncogene , 1999, The EMBO journal.
[4] E. Algar,et al. Mutation analysis of the WT1 gene in sporadic childhood leukaemia , 1997, Leukemia.
[5] Y. Oji,et al. Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). , 1999, Leukemia research.
[6] Z. Wang,et al. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain. , 1999, Biochemical and biophysical research communications.
[7] J. Bard,et al. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo , 1993, Mechanisms of Development.
[8] V. Sukhatme,et al. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] Y. Oji,et al. Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth , 1999, Japanese journal of cancer research : Gann.
[10] F. Rauscher,et al. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. , 1996, Nucleic acids research.
[11] D. Haber,et al. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. , 1995, The EMBO journal.
[12] M. Little,et al. A clinical overview of WT1 gene mutations , 1997, Human mutation.
[13] W. Gerald,et al. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Smith,et al. Zinc finger point mutations within the WT1 gene in Wilms tumor patients. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] E. Bertelmann,et al. Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens , 2000, Journal of Cancer Research and Clinical Oncology.
[16] W. Gerald,et al. The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin , 1999, Cell.
[17] E. Algar,et al. Overexpression of murine WT1 + / + and - / - isoforms has no effect on chemoresistance but delays differentiation in the K562 leukemia cell line. , 2000, Leukemia research.
[18] J. Licht,et al. E-cadherin Is a WT1 Target Gene* , 2000, The Journal of Biological Chemistry.
[19] David Housman,et al. WT-1 is required for early kidney development , 1993, Cell.
[20] Amy Bernard,et al. The Wilms tumour gene WT1 is expressed in murine mesoderm–derived tissues and mutated in a human mesothelioma , 1993, Nature Genetics.
[21] P. Smith,et al. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. , 1996, Oncogene.
[22] A. Jochemsen,et al. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.